Kanchan Shah1, Bhavana Valvi2*, Prashant Pandilwar3, Suraj Parmar2 and Wahab Shaikh1
1Associate Professor, Department of Oral and Maxillofacial Surgery, Government Dental College and Hospital, Aurangabad, Maharashtra, India 2Assistant Professor, Department of Oral and Maxillofacial Surgery, Government Dental College and Hospital, Nagpur, Maharashtra, India 3Professor and Head, Department of Oral and Maxillofacial Surgery, Government Dental College and Hospital, Aurangabad, Maharashtra, India
*Corresponding Author: Bhavana Valvi, Assistant Professor, Department of Oral and Maxillofacial Surgery, Government Dental College and Hospital, Nagpur, Maharashtra, India.
Received: October 20, 2021; Published: December 09, 2021
Post COVID Mucormycosis is declared epidemic in India after 2nd wave. Corticosteroids are widely use in the management of COVID 19, which causes tremendous immunosuppression and gives birth to various opportunistic bacterial and viral infections like, Mucormycosis which is a lethal or deadly infection which kills the patient or made the person physically handicapped. Mucormycosis is common in maxilla and rare in mandible. We are presenting a case report of a 55 years old male patient having post COVID Mucormycosis along with osteomyelitis of the mandible, the rarest form of the post COVID infection, which was managed surgically as well as with adjuvant medicinal management followed by post-operative prosthetic rehabilitation.
Keyword: Post COVID Mucormycosis; Osteomyelitis
Citation: Bhavana Valvi., et al. “Post Covid 19 - Mucormycosis and Osteomyelitis of the Mandible- A Rare Case Report". Acta Scientific Otolaryngology 4.2 (2022): 18-22.
Copyright: © 2022 Bhavana Valvi., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.